Read our blog
What we have to say about tech and biotech...
tax is more exciting than you might think!
Latest posts
Research and development (R&D) tax reliefs for SMEs have been refined and will offer some much-needed support for life sciences and tech…
R&D tax reliefs are very much in the news, due in large part to major changes being made to the schemes by Government. The past decade…
November 11, 2021 Cambridge, UK – Confluence Tax has today announced it is to merge with a US counterpart, Frazier & Deeter, headquartered out of…
R&D tax credits: consultation response 2021
The Chancellor of the ExchequerHM Treasury1 Horse Guards RoadLondonSW1A 2HQ June 2, 2021 By email: RDTaxReliefs@hmtreasury.gov.uk Dear Chancellor, R&D Tax Reliefs: consultation Thank you for the…
Enterprise Management Incentives (EMI): Confluence Tax response 2021
The Chancellor of the ExchequerHM Treasury1 Horse Guards RoadLondon SW1A 2HQ May 24, 2021 Dear Chancellor, Enterprise Management Incentives: call for evidence Thank you for the…
EMPLOYMENT related securities (ERS) are a common way of incentivising employees within the technology and biotechnology industries. However, issuing shares or share options results in a…
The Employee Equity Survey was run for biotech companies to enable them to benchmark equity distribution and the size of share option pools..
But there is no need to panic as most companies, including those in biotech and tech, will be minimally affected by the changes. The PAYE cap legislation around SME…
THE 2020 Budget was an interesting one, especially for biotech companies. Confluence Tax’s team presented the headline points during the company’s Post-Budget Briefing event held on March 12. The focus was on the main elements that will affect companies from a tax and finance perspective.